Institutional Ownership Mereo Biopharma Group PLC (MREO)
This table provides information about the institutional ownership of Mereo Biopharma Group PLC (MREO). We have compiled data on the 84 institutions that hold shares in the stock, with a total of 107 Million shares, which have been reported (via 13F filing form) to have a value of $353 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rubric Capital Management LP
New York, NY |
Nov 13, 2024 Q3 2024 |
15,307,347
shares
|
$51.3 Million
1.75% of portfolio
|
Q2 2024
Added 12.94%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
12,345,866
shares
|
$41.4 Million
0.03% of portfolio
|
Q3 2024
Added 56.66%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
9,715,013
shares
|
$32.5 Million
0.07% of portfolio
|
Q3 2024
Reduced 17.61%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
9,534,170
shares
|
$31.9 Million
1.33% of portfolio
|
Q3 2024
Added 2.7%
|
|
|
Mangrove Partners
New York, NY |
Nov 14, 2024 Q3 2024 |
8,729,720
shares
|
$29.2 Million
4.66% of portfolio
|
Q3 2024
Reduced 0.26%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
6,710,429
shares
|
$22.5 Million
0.51% of portfolio
|
Q2 2024
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
5,394,691
shares
|
$18.1 Million
0.01% of portfolio
|
Q3 2024
Added 68.49%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
5,097,779
shares
|
$17.1 Million
1.13% of portfolio
|
Q3 2024
Added 15.82%
|
|
|
683 Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
4,849,800
shares
|
$16.2 Million
1.81% of portfolio
|
Q3 2024
Reduced 3.0%
|
|
|
Alkeon Capital Management LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
4,698,100
shares
|
$15.7 Million
0.03% of portfolio
|
Q2 2024
Added 10.85%
|
|
|
Clearline Capital LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,244,334
shares
|
$10.9 Million
0.59% of portfolio
|
Q3 2024
Reduced 2.48%
|
|
|
Tejara Capital LTD
London, X0 |
Nov 13, 2024 Q3 2024 |
2,829,990
shares
|
$9.48 Million
5.54% of portfolio
|
Q3 2024
Added 8.2%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
2,347,825
shares
|
$7.87 Million
0.0% of portfolio
|
Q3 2024
Added 1030.2%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
2,008,381
shares
|
$6.73 Million
0.0% of portfolio
|
Q3 2024
Reduced 19.91%
|
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
1,551,082
shares
|
$5.2 Million
0.08% of portfolio
|
Q3 2021
Added 48.46%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
1,305,371
shares
|
$4.37 Million
0.01% of portfolio
|
Q3 2024
Reduced 25.92%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Nov 14, 2024 Q3 2024 |
1,260,700
shares
|
$4.22 Million
5.25% of portfolio
|
Q3 2024
Added 86.22%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
1,028,512
shares
|
$3.45 Million
0.01% of portfolio
|
Q3 2024
Reduced 10.1%
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2024 Q3 2024 |
1,000,000
shares
|
$3.35 Million
0.48% of portfolio
|
Q3 2024
Reduced 43.66%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Nov 14, 2024 Q3 2024 |
847,809
shares
|
$2.84 Million
1.15% of portfolio
|
Q3 2024
Reduced 5.57%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
846,953
shares
|
$2.84 Million
0.3% of portfolio
|
Q3 2024
Reduced 32.08%
|
|
|
Neos Investment Management LLC
Westport, CT |
Nov 13, 2024 Q3 2024 |
835,194
shares
|
$2.8 Million
0.1% of portfolio
|
Q3 2024
Reduced 12.95%
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
815,722
shares
|
$2.73 Million
0.09% of portfolio
|
Q3 2024
Reduced 34.91%
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
777,890
shares
|
$2.61 Million
0.25% of portfolio
|
Q3 2024
Added 56.78%
|
|
|
Artia Global Partners LP
Miami, FL |
Nov 14, 2024 Q3 2024 |
421,359
shares
|
$1.41 Million
0.47% of portfolio
|
Q1 2024
New holding
|